Invention Application
- Patent Title: QUINOXALINE COMPOUND
- Patent Title (中): 喹啉化合物
-
Application No.: US13254368Application Date: 2010-03-04
-
Publication No.: US20110319385A1Publication Date: 2011-12-29
- Inventor: Hiroyuki Kaizawa , Mari Sugita , Hidenori Azami , Ryushi Seo , Takaho Nomura , Satoshi Yamamoto , Hirofumi Yamamoto , Kazuyuki Tsuchiya , Hideki Kubota , Kazunori Kamijo
- Applicant: Hiroyuki Kaizawa , Mari Sugita , Hidenori Azami , Ryushi Seo , Takaho Nomura , Satoshi Yamamoto , Hirofumi Yamamoto , Kazuyuki Tsuchiya , Hideki Kubota , Kazunori Kamijo
- Applicant Address: JP Tokyo
- Assignee: Astellas Pharma Inc.
- Current Assignee: Astellas Pharma Inc.
- Current Assignee Address: JP Tokyo
- Priority: JP2009-052577 20090305
- International Application: PCT/JP2010/053586 WO 20100304
- Main IPC: A61K31/4985
- IPC: A61K31/4985 ; C07D413/14 ; A61P13/00 ; A61K31/5377 ; A61K31/55 ; C07D487/04 ; C07D403/14
Abstract:
[Problem]Provided is a compound which has a PDE9-inhibiting action and is useful as an active ingredient for an agent for treating and/or preventing storage dysfunction, voiding dysfunction, and bladder/urethral diseases, and the like.[Means for Solution]The present inventors have investigated a compound which has a PDE9-inhibiting action and is useful as an active ingredient for an agent for treating and/or preventing storage dysfunction, voiding dysfunction, and bladder/urethral diseases, and the like, and thus, have found that an imidazoquinoxaline compound or a triazoloquinoxaline compound has a PDE9-inhibiting action, thereby completing the present invention. The imidazoquinoxaline compound or the triazoloquinoxaline compound of the present invention has a PDE9-inhibiting action and can be used as an agent for preventing and/or treating storage dysfunction, voiding dysfunction, and bladder/urethral diseases, and the like.
Public/Granted literature
- US08357688B2 Substituted imidazo[1,5-a]quinoxalin-4(5H)-ones as PDE9 inhibitors Public/Granted day:2013-01-22
Information query
IPC分类:
